chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I experienced 3 strokes consecutively. First one came when I was sitting in the couch and they took me to the hospital. They took me in and we stayed there for about 2-3 days (Can't focus) and then they dispatched me. I was pretty messed up. Then I spent like the next 2 weeks with micro strokes. I didn't know what was going on and went back to the hospital only for them to send me back home. Shortly after that, I saw Dr. and told him that I wasn't feeling well and went home. At about 4 o'clock I took a shower and didn't feel well. My wife drove me to the hospital and when I went I couldn't do anything. I got shots for strokes and took me to a bed. That is where I stayed and saw Dr. who told me that I got a stroke. I stayed there for 3 days and they sent me home. By now, I have lost my eyes, speech and it is really hard to focus or remember everything. I was going to a speech therapist and walk funny. I was stumbling at home.
Approximately 3 days after 1st shot I became ill and was diagnosed with Shingles  due to small rash on arm. Several days before my 2nd shot I felt much better and assumed the Shingles bout was over. Then, 3 days after 2nd shot I once again got ill with Shingles and that bout lasted 6 weeks. I have since encountered two other individuals who had the same experience.
Case number PHEH2014US019250, is an initial spontaneous report received from a nurse on 24 Sep 2014. This report refers to an 11 year old male patient. His medical history and concomitant medication was not reported. He received MENVEO (batch number: A14044) subcutaneously in the side of the leg on 19 Sep 2014. Nurse reported that the decision to administer MENVEO in the leg was because the patient was too young and too skinny to get it into the arm. On 20 Sep 2014, the injection site had a "large, red whelp." On 21 Sep 2014, the size of the "large, red whelp" increased to 4 inches. He was given BENADRYL and DEPO-MEDROL at a dose of 40 mg on 21 Sep 2014 which helped lessen the severity of the adverse event. Outcome of the event was unknown. Seriousness and causality assessment was not reported.
misses her period/I have never ever missed a period and I missed a period; I am experiencing side effects from the shot; This is a spontaneous report from a contactable consumer (patient herself). A 39-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: FC3181), via an unspecified route of administration on 10Aug2021 (age at vaccination: 39 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unknown date in August2021, she missed her period/ have never ever missed a period, she was experiencing side effects from the shot. She has always been in incredible health. She wanted to know what damage has been done to her that she might not be able to fix, she needs to get the ball rolling on how to get her body back to functioning the way it should, wants to know what the vaccine has done that has impacted her body not make it work. The outcome of the events was unknown. There was no product quality complaint (PQC) present.   The lot number for the vaccine was not provided and will be requested during follow up.
Case was hospitalized for Covid after being vaccinated for it.  Acute respiratory failure with hypoxia (HCC) Assessment & Plan Patient presented with acute respiratory failure with hypoxia secondary to COVID-19 infection and superimposed bacterial pneumonia. Treating underlying COVID-19 infection as well as bacterial pneumonia. On 2L today. Patient with underlying COPD and sufficient to oxygenate 88 to 92%. Home oxygen was arranged on discharge, I recommended she follow-up with her PCP to determine ongoing oxygen need as an outpatient. Instructed her to avoid smoking or flammable material while wearing oxygen.  Pneumonia Assessment & Plan Patient has a COVID-19 infection but I think this is probably mostly bacterial pneumonia. Chest x-ray consistent with this and did not reveal the diffuse inflammatory process we typically see. Electing to treat with dexamethasone 6 mg p.o. daily either way. Started on CAP abx with ceftriaxone, azithromycin, day 3 antibiotics, switched to Ceftin to complete 5 additional days.    COVID-19 Assessment & Plan Patient with negative COVID-19 test in the outpatient setting 2 weeks prior but with concurrent respiratory symptoms that have progressively worsened. Patient intermittently treated with antibiotics and steroids which temporarily improved her condition. Patient now presented to emergency room with hypoxia, cough, shortness of breath. CXR with more of a lobar infiltrate. Suspect both bacterial and covid pneumonia. Dexamethasone 6 mg p.o. every 24 hours, holding home prednisone for now. Concurrent treatment for superimposed bacterial infection with Ceftin on discharge. Supportive management, incentive spirometry, upright posture, ambulation encouraged. RT to eval and treat. Albuterol available for support. Doctor evaluated her and is testing her for antibodies in case her Covid worsens, she might be a candidate for monoclonal antibody use if negative antibodies result
20 x 20cm edematous, painful area to R arm from shoulder to below deltoid limited ROM to arm
About 20 minutes after injection "felt jittery" and took her blood pressure 181/103 Pulse 95. Normally blood pressure runs 130/80. Retaken at 10:08 am 150/118, 10:27am 150/100, 11 am  160/94.
fever just over 100 degrees F x 24 h, headache and vomiting-entire episode resolved after 24 hours.
Weakness and leg tingling 20 minutes after shot. Headache developed and became aggravated during the night. Next am shaking, chills and fever five degrees over normal (100.8)
Redness, swelling, hot to touch at the injection site. Inflammation was about softball size around injection site. Inflammation first appeared within hours of injection. Low-grade fever (highest recorded 99.8). Fever first recorded around 1pm 7/18/18 (next day). Varicella rash- about 10 pustules total on trunk, legs, and around injection site. (First spots appeared in the evening on 7/18/18).
12 hrs after injection started having fever. 4 hours later vomiting, couldn't stop gaging. laid on the floor 5 hours dizzy. daughter gave her Tylenol and some coke. was able to keep some crackers down.  for 24 hours stayed on light diet to not vomit. by two days later started to turn the corner. but since Sunday the 17th i have had a light fever and slight nausea. Tuesday 1/19/2020 I started to get bumps on hand and arm and on chin. they come and go. today 01/22/2020 still have fever and few bumps on hand and arm still.  have had diarrhea a few times.
Severe joint pain starting about 8 hours after injection with no change in last 2 weeks.  Every joint hurts starting at my neck and going all the way to my toes and fingers, Inflammation in all areas.
Patient was given vaccine that had been in refrigerated temperature for 7 days (outside length of time advised per manufacturer). No adverse events have been reported at this time. We are speaking with Pfizer regarding re-immunization.
42 yr old male without comorbidities in general good health. 12/27/21 ER Visit for left neck lymphadenopathy just over 2 centimeters with 2-2 1/2 months (approximately September 2021) pruritus, gradual progressive swelling in neck and now right groin swelling. Dermatology has ruled out any scabies or bed bugs, now has been diagnosed with allergic dermatitis. Augmentin 875mg po x 7 days ordered without improvement. additional symptoms today include: nonproductive cough, fever, nausea, vomiting. 12/28/21 Admission to Hospital for severe nausea & vomiting. Right groin lymph node biopsy complete with positive diagnosis of T-cell lymphoma. 1/7/21 symptomatic covid19 positive. 1/10/22 Symptomatic covid 19 positive with moist cough with intermittent nausea & vomiting.  Hepatitis Negative. HIV negative. CMV negative. 1/20/22 Outpatient surgical procedure for left neck lymph node biopsy. Covid19 negative. fever 100 oral, tachycardia rate 130's. Surgeon is Doctor.
Secondary reaction ("take") at 1100 position to primary smallpox innoculation.  Pt c/o excessive itching - but denies scratching site.  Site covered w/ occlusive dressing since 5 March 03 - no drainage on outside of bandage.
Information has been received from a registered nurse concerning her 19 year old daughter who on an unspecified date was vaccinated in the buttocks with a first dose of Gardasil.  Subsequently the patient developed pain at the injection site that was "black and blue".  On 23-AUG-2007 the patient was vaccinated in the buttocks with a 1.5 inch needle with a 10 cc syringe second dose of Gardasil.  Subsequently the "drug leaked out."  At the time of the report the patient's outcome was unknown.  Additional information has been requested.
After receiving the INFLUENZA shot the patient became lightheaded, then sweaty, dizziness, about 2 minutes later she fainted for a few seconds. In 5 minutes she was fine. EMTs took BP - normal, pulse-slow, pulse ox - was low. Pt refuse transport and went home.
Patient's mother called 8/4/11 & reported patient's (R) arm was red & swollen. Advised to apply cold compresses.
I tested positive for COVID-19, I reached out to my doctor and was prescribe medication. The symptoms I had was a fever, fatigue, and cough. They symptoms are starting to easy up.
Got a rash on Sunday night, the day after the vaccine.  Rash was  mostly gone within a few days.  Now peeling skin.
Local Right upper outer arm; red swollen, hot and itching; aprox 12cm x 8cm x 5 days.  Low grade fever.  Symptoms less on day 6.  No official treatment required, used NSAID for symptom management. SHINGLES VACCINE
This spontaneous report was received from a physician and it refers to a currently 2 year old female patient. The patient has no medical history and no previous drug reactions and allergies. On 12-SEP-2013, the patient was vaccinated with one dose of (Oka/Merck) PROQUAD lot # J004321, exp date: 17-OCT-2014, dose: 0.5 ml, subcutaneous (anatomical location was not reported). There was no concomitant medication. In October 2014, reported as "last week" antibody titers test was performed and antibody titers were found to be negative for measles, mumps, rubella and varicella. The patient sought medical attention, she had an office visit on an unspecified date. No treatment was given for the events. The outcome of the events was unknown (the patient's present status was reported as negative antibody titers). The relatedness between vaccination with (Oka/Merck) PROQUAD and the event was not reported. Additional information is not expected, the reporter does not wish to be contacted.
Pt stated she had fevers/chills and redness/swelling around the injection site as well as localized itching on right arm.
Developed red, swollen, itchy rash at the injection site. The redness of the skin appeared the size and shape of a large potato around the injection site. Applied topical cortisone one time to alleviate the itchiness. Swelling and redness decreased after 24 hours. Itchiness did not decrease until 48 hours. Still have faded red rash at injection site as of Apr 12th.
Initial report was received from the consumer on 22 Jan 2010. The patient was vaccinated with a 0.5 ml dose of FLUVIRIN in her left deltoid on 16 Jan 2010. Eighteen hours after receiving the vaccine on the same day, the patient experienced an intense tingling on the right side of her leg, extending from the knee to the toes. On 19 Jan 2010, the patient experienced that her legs were trembling uncontrollably, which caused her to see a neurologist. The patient was not recovered from the events at the time of the report. The seriousness criteria of the events was not reported.
My back started aching and I also got a mild headache. The next morning, I woke up with a worse headache, a worse backache and both legs below the knee were aching when I walked. I had no fever. It was like a mild flu without any fever.
Hive like rash around injection site; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE URTICARIA (Hive like rash around injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced INJECTION SITE URTICARIA (Hive like rash around injection site). At the time of the report, INJECTION SITE URTICARIA (Hive like rash around injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
DTaP to right thigh one day later with swelling and itching to area. Max 4cmx6cm.
Unknown vaccinated date, cannot locate. Patient reported J/J dose x1 received "couple months ago".  Now to ED and admitted for observation, positive for COVID 9/19/2021, diagnosed with COVID pneumonia.   O 2sat 92-94% on RA, did not require oxygen and was discharged home next day.
10 AM burning in throat, chest heaviness. 1 PM wheezing, coughing, shortness of breath, eyes bloodshot.
Hospitalized 10/28/2021; COVID-19 positive 10/28/2021; fully vaccinated  BRIEF OVERVIEW:  Admission Date: 10/28/2021 Discharge Date: 10/29/2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COVID-19 [U07.1] COVID-19 in immunocompromised patient [U07.1, D84.9] HOSPITAL COURSE: Patient is a 51 y.o. male with past medical history of end-stage heart failure s/p OHT 10/22/2017 on immunosuppressant therapy, DM II, HTN, HLD, anemia, OSA, anxiety/deression ; he presented with 3 days of fever, chills, sweats, sore throat, headache, nausea, vomiting.  He tested positive for COVID on 10/28/21, he did receive his 3rd Pfizer COVID vaccine on 10/6/21.   He was unable to keep down 2 days of medicines due to significant vomiting.  Vomiting resolved with fluid hydration and he had no vomiting while in the hospital.  Due to symptomatic COVID infection, he received monoclonal antibody as recommended by Infectious Disease consultation.  He was able to tolerate oral intake and keep his medications down and was safe for discharge. CONSULTS / RECOMMENDATION: Per infectious disease recommendations, 20 days of isolation due to COVID infection.
Moderate fever, arm pain, high heart rate, high blood pressure, high WBC, high Absolute Neutrophil
1wk p/vax pt devel diffuse, red urticarial type rash involving the chest, abd, back & inner thighs of pt;pt was put on pred, atarax & hytone cream;
Pt had muscle soreness, site of injection pain, temp ranging from 100.1 to 101.8, rigors, chills.
I had a stroke sometime between 11pm on April 22, 2021 and 8am on April 23, 2021.   I'd had the vaccine at 4pm on April 21, 2021.  I felt ill during the day on 4/22/2021 but took a nap and woke up feeling better before heading to bed at about 10pm.
Patient is stating that she is experiencing slight hearing loss.  No mention of ringing in the ears.  She can hear, but not very well.  Discussed with patient's husband and told him I would do some further research into this in addition to filling out the VAERS report.  She will also contact her primary care.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2011, the patient was inoculated with ZOSTAVAX at a clinic as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of shingles, or severe herpes zoster. On or about 17-JAN-2012, the patient was treated in a clinic for the diagnosis as of post herpetic neuralgia, a chronic condition of pain and nerve damage secondary to herpes zoster infections. She was prescribed Acyclovir for management of her painful symptoms and chronic pain. As a direct and proximate result of the defective ZOSTAVAX vaccine, the patient suffered and continues to suffer painful and ongoing injuries and damages, and required and continues to require extensive medical care and treatment. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
pt recv vax 18JUL98 & papular vesicular eruption note 30DEC98;
Red sore arm; Red sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Red sore arm) and ERYTHEMA (Red sore arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Red sore arm) and ERYTHEMA (Red sore arm). At the time of the report, PAIN IN EXTREMITY (Red sore arm) and ERYTHEMA (Red sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
A report has been received from a Health Professional concerning a 9 year old, Female subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 17-Feb-2016. Nurse reported that she had administered an expired FLUMIST QUADRIVALENT to a 9 year old on 17-Feb-2016. The outcome of the event of administration of expired lot is unknown. The reporter's description of the events was as follows: healthy child. The report was considered to be non-serious.
Syncope at time of injection. Legs elevated, cold cloth to face; sips of sprite provided when able. Child  - dad present I called child's MD who confirmed syncope due to anxiety.
Patient passed out after administering vaccines mom laid patient on the floor, physician and medical assistant called into room, laid patient on bed, vital signs checked by medical assistant, rechecked again in 15 minutes, vital signs were stable. Patient given apple juice and patient cleared to go home by physician.
pain in her chest between her clavicle and top portion of her breast area/soreness in chest/fluttery sensation in her chest; She was feeling funny, never felt like that before; Experiencing shortness of breathe/rates her breathing as a 5; This is a spontaneous report from a contactable consumer (patient mother), who is a nurse. A 19-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration, on 15May2021 at a single dose for Covid-19 immunization. Patient medical history and concomitant medications were not reported. The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported) via an unspecified route of administration, on an unspecified date at a single dose for Covid-19 immunization. On 25May2021, the patient experienced pain in her chest between her clavicle and top portion of her breast area/pain or soreness in her chest and describes a fluttery sensation in her chest that "feels funny, uncomfortable, weird, and not right. The patient had shortness of breath on an unspecified date in May2021. The patient woke up with a "funny sensation in her chest" and does not describe excruciating pain or difficulty breathing and "rates her breathing as a 5."The patient did not eat anything out of the ordinary or participated in any lifting or exercising of her chest muscles. Patient had never complained of anything like this before. The outcome of events was unknown.  Additional information has been requested.; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2 and the events, Dyspnea, chest pain, feeling uncomfortable cannot be completely ruled out. The impact of this report on benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethic committees, and Investigators, as appropriate.
4/4/21 Swelling below waist, including buttocks, hips, thighs, and knees. Severe itching and pain. 4/7/21 Swelling spread to calves and ankles. Severe pain and itching. PCP prescribed 50 mg Benadryl every 6 hours and was told to go to Urgent Care if symptoms persist. 4/9/21 Went to Urgent Care Clinic due to excruciating pain in legs. Admitted to accompanying ER. Received IV and had blood drawn, showing extremely low platelet levels (37k). Discharged with prescription for antihistamine, steroid, and hydroxyzine HCL. Ultrasound taken but did not show blood clots. 4/11/21 Pain and itching spread to both arms. Extreme pain when standing and walking. 4/13/21 Went to ER. Ultrasound confirmed multiple blood clots. Discharged with prescription for Xarelto.
Nausea, abdominal pain, headaches, dizziness, wobbly legs, vision sensitive to lights, stings, numbness, unable to move when sleeping, heard voices while sleeping, sinus infection, itching severely, and muscle spasms. 1/19/09 Reviewed ER medical records of 9/12-10/09/2008. FINAL DX: Records reveal patient bitten or scratched by bat 2 days prior while out of state.  Tx w/rabies immunoglobulin into the abrasions on right forearm & also rabies vaccination series initiated.  Returned to ER 9/26 for Td & c/o numbness & tingling all over & auditory hallucinations.  Developed stinging sensation over right forearm.  By 10/9 symptoms had resolved.
This spontaneous report as received from a registered nurse refers to a 8 year old patient of unknown gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 07-JAN-2016, the patient was vaccinated with GARDASIL 9 lot # L028083, expiration date: 03-SEP-2017, which was outside the recommendations per the GARDASIL 9 prescribing information. No adverse effects were reported. Additional information has been requested.
Influenzas (type unknown): No injection site pain; developed sore throat, draining sinuses,  slight cough within 24 hours; throat pain and drainage increased and general tiredness began over next 24 hours, no fever as yet,  Symptoms of flu persist after 48 hours.
Case number PHEH2014US021089, is an initial spontaneous report from a pharmacist received on 16 Oct 2014. This report refers to a 15-year-old female patient. Her medical history and concomitant medications were not reported. On 15 Oct 2014, the patient inadvertently received an intramuscular dose of FLUCELVAX (batch number: 015011A) instead of FLUVIRIN (batch number: unknown). No adverse event was reported following this medication error.
Rec. vaccine 12 N 12/8/14. 830pm N and V. Temp 102. 9pm upper left arm swollen, red, hot to touch.
Sulfur taste and smell about a month after second dose.   Coffee Peanut Butter   Sulfur taste in my mouth all the time
Pain and numbness on L forearm near the injection site Mild hypertension and tachycardia
A severe rash, beginning at the back of my neck, from where it proceded to cover my whole neck, ears, face, chest, arms, hands, back, thighs, and a little on my lower legs.
The arm where injection was given is very painful from the shoulder to the elbow. It is difficult to move, regardless of pain.
Within 8 hours of administration c/o nausea, lethargy, headache, chills, and dizziness. Extreme site tenderness.
Violent chills began just after midnight on 3/22 (my whole body was shaking and teeth were chattering uncontrollably). Noted fever of 101.5 at 1:30 am with extreme fatigue/weakness, headache. As of 8:30 am, still had fever, 101.7. I took Tylenol at 8:30 am and as of 9:27 am, my temperature is 100.7